RN7SL679P

Across TCGA pan-cancer cohorts, RN7SL679P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RN7SL679P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SL679P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL679P expression acts as an unfavorable survival marker, although some lineages such as HNSC and COAD show a favorable association.

BRCA, ACC, and HNSC are the cancer types where RN7SL679P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.547	0.808	.002	63	view →
ACC	OS	Tertile	All	0.156	0.705	.005	60	view →
HNSC	OS	Tertile	All	0.977	0.674	.006	51	view →
THCA	DFS	Tertile	III,IV	0.157	0.777	<.001	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	42	view →
SKCM	OS	Tertile	All	0.674	0.798	.020	30	view →
KIRC	DFS	Tertile	III,IV	0.303	0.523	.023	27	view →
SARC	OS	Tertile	All	0.157	0.524	.004	18	view →
LIHC	OS	Tertile	II,III,IV	0.135	0.626	.015	18	view →
BLCA	DFS	Tertile	III,IV	0.172	0.332	.034	15	view →
PCPG	DFS	Tertile	All	0.754	0.931	.017	15	view →
STAD	DFS	Quartile	All	0.503	0.725	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RN7SL679P–BRCA (DFS)

Open the BRCA breakdown →